 | Up a level |
Tremblay, J. P., Xiao, X., Aartsma-Rus, A., Barbas, C., Blau, H. M., Bogdanove, A. J., Boycott, K., Braun, S., Breakefield, X. O., Bueren, J. A., Buschmann, M. D., Byrne, B. J., Calos, M., Cathomen, T., Chamberlain, J., Chuah, M., Cornetta, K., Davies, K. E., Dickson, J. G., ... Gao, G. (2013). Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy, 21(2), 266-268. Available
Venereo-Sanchez, A., Fulton, K., Koczka, K., Twine, S., Chahal, P., Ansorge, S., Gilbert, R., Henry, O., & Kamen, A. (2019). Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF. Vaccine, 37(47), 7100-7107. External link
Venereo-Sanchez, A., Simoneau, M., Lanthier, S., Chahal, P., Bourget, L., Ansorge, S., Gilbert, R., Henry, O., & Kamen, A. (2017). Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line. Vaccine, 35(33), 4220-4228. External link
Venereo-Sanchez, A., Gilbert, R., Simoneau, M., Caron, A., Chahal, P., Chen, W., Ansorge, S., Li, X., Henry, O., & Kamen, A. (2016). Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate. Vaccine, 34(29), 3371-3380. External link
